NEW YORK, May 21, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding RetailMeNot Inc (NASDAQ: SALE), The Advisory Board Company (NASDAQ: ABCO), HMS Holdings Corp (NASDAQ: HMSY), MAXIMUS, Inc. (NYSE: MMS) and SYNNEX Corporation (NYSE: SNX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2731-100free.
--
RetailMeNot Inc Analyst Notes
On May 14, 2014, RetailMeNot Inc (RetailMeNot) announced that its CFO Douglas Jeffries, will present at two upcoming Conferences. The first presentation will be on June 4, 2014, at Goldman Sachs Fifth Annual dotCommerce Day at the Mandarin Oriental in New York, New York, with the presentation expected to start at 7:15 a.m. CT (8:15 a.m. ET). The second presentation will be on June 11, 2014, at 9:20 a.m. CT (10:20 a.m. ET) at William Blair 2014 Growth Stock Conference to be held at The Four Seasons in Chicago, Illinois. According to the Company, the presentations will be webcast live and will be made available on the Company website's investor relations section. Additionally, a replay will also be made available for 90 days at the same location. The full analyst notes on RetailMeNot are available to download free of charge at:
http://www.analystsreview.com/2731-SALE-21May2014.pdf
--
The Advisory Board Company Analyst Notes
On May 15, 2014, The Advisory Board Company (The Advisory Board) presented MissionPoint Health Partners and Hospital Corporation of America's (HCA) South Atlantic Division with the 2014 Crimson Physician Partnership Award in its national Crimson summit in Orlando. According to the Company, the award is bestowed to organizations that demonstrate exemplary results in aligning the efforts of physicians and health systems to deliver higher quality and effective care to patients that participate in the Company's Crimson Clinical Advantage suite of programs. The Company stated that MissionPoint focuses with population and physician analytics and workflow solutions directly while HCA deployed physician analytics for goal-setting, action plan development and physician training to reduce unnecessary clinical variation and enhance physician engagement. The full analyst notes on The Advisory Board are available to download free of charge at:
http://www.analystsreview.com/2731-ABCO-21May2014.pdf
--
HMS Holdings Corp Analyst Notes
On May 9, 2014, HMS Holdings Corp (HMS Holdings) reported its Q1 2014 financial results. Revenue fell 10.2%YoY to $104.7 million. Net income stood at $3.4 million, or $0.04 per fully diluted share, compared with $7.0 million, or $0.08 per fully diluted share in Q1 2013. According to Bill Lucia, President and CEO, HMS Holdings, the financial results reflect the effects of extended Medicare RAC reprocurement process, however, majority of the business remains strong and it is beginning to show positive effects of ACA-fueled Medicaid expansion. Lucia commented, "As we move through 2014, we are focused on capitalizing on these growth areas, reducing our cost structure, and exploring new ways to further strengthen the company. We maintain our strong support for the Medicare RAC program as the most effective tool in the nation for protecting the Medicare Trust Fund, and look forward to CMS issuing contract awards." The full analyst notes on HMS Holdings are available to download free of charge at:
http://www.analystsreview.com/2731-HMSY-21May2014.pdf
--
MAXIMUS, Inc. Analyst Notes
On May 8, 2014, MAXIMUS, Inc. (MAXIMUS) reported its Q2 FY 2014 financial results (period ended March 31, 2014). Revenue increased 34.5%YoY to $439.0 million. Net income registered $41.2 million, or $0.59 diluted earnings per share, compared with $31.7 million, or $0.45 diluted earnings per share in Q2 FY 2013. According to the Company, revenue growth was driven primarily by organic growth in the Health Services Segment from new work and expansion on existing contracts, much of which was related to Affordable Care Act (ACA). Adjusted diluted earnings per share grew 64.0% YoY to $0.59. Maximus stated that the increase in earnings is primarily attributed to accretive growth in Health Services Segment. For full-year FY 2014, the Company expects revenue to range between $1.68 billion and $1.73 billion and diluted earnings per share from continuing operations to range between $2.00 and $2.10. The full analyst notes on MAXIMUS are available to download free of charge at:
http://www.analystsreview.com/2731-MMS-21May2014.pdf
--
SYNNEX Corporation Analyst Notes
On May 9, 2014, Concentrix Corporation -a wholly owned subsidiary of SYNNEX Corporation (SYNNEX) announced that its 10th client went into production on the latest version of the Concentrix Insurance Solutions (CIS) industry-leading policy administration software platform, GIAS. According to the Company, CIS provides flexible deployment choices for GIAS clients, including directly licensed software as a service (SaaS) or full back office administration through business process as a service (BPaaS). The Company informed that GIAS provides processing for a full range of life, health, and annuity products for individuals, groups, and voluntary / worksite markets, enabling faster product development, greater process automation and higher quality interactions with customers. Michael Stricker, Chief Administrative Officer, Sagicor Life Insurance Company, said, "GIAS allows us to rapidly respond to shifting customer demands by speeding the introduction of new products and by allowing us to quickly adapt those products to market feedback." The full analyst notes on SYNNEX are available to download free of charge at:
http://www.analystsreview.com/2731-SNX-21May2014.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
